Matches in Wikidata for { <http://www.wikidata.org/entity/Q65538931> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65538931 description "clinical trial" @default.
- Q65538931 description "ensayu clínicu" @default.
- Q65538931 description "klinisch onderzoek" @default.
- Q65538931 description "клінічне випробування" @default.
- Q65538931 name "Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus" @default.
- Q65538931 name "Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus" @default.
- Q65538931 type Item @default.
- Q65538931 label "Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus" @default.
- Q65538931 label "Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus" @default.
- Q65538931 prefLabel "Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus" @default.
- Q65538931 prefLabel "Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus" @default.
- Q65538931 P1050 Q65538931-A7A0B211-5554-4BEF-B66A-8D7373167996 @default.
- Q65538931 P1132 Q65538931-B3E87763-314B-4D39-B518-A6A7756446B8 @default.
- Q65538931 P1476 Q65538931-B1C6FBB5-6282-47EE-A768-4F5FF5BA4FE1 @default.
- Q65538931 P17 Q65538931-0A0C3D9A-3881-4B4E-9AB2-3EF18033A2A1 @default.
- Q65538931 P2899 Q65538931-F231C8A0-60D7-4E11-A1BE-09968C573423 @default.
- Q65538931 P3098 Q65538931-CC2F7862-CE59-4659-AC6E-B2D457658AD0 @default.
- Q65538931 P31 Q65538931-FAAD2B51-3D9D-4007-8F91-0DFB4C1AE0EB @default.
- Q65538931 P4135 Q65538931-451DCAB0-C368-4CCB-BA6A-6A270D54F0A2 @default.
- Q65538931 P4844 Q65538931-F1A5A724-A89C-48CF-85BD-725A1C6E523F @default.
- Q65538931 P580 Q65538931-C205A414-2272-47C6-BFA1-E4D0C218A9FF @default.
- Q65538931 P6099 Q65538931-F1FAD673-7F0E-48E3-8CC1-93951D2101C1 @default.
- Q65538931 P6153 Q65538931-86E62DEB-5DCD-40E7-8F03-9A7F0D0EFF57 @default.
- Q65538931 P8363 Q65538931-9DB6D6A8-17CE-41F1-8DEF-D9FF809D35E1 @default.
- Q65538931 P1050 Q12206 @default.
- Q65538931 P1132 "+390" @default.
- Q65538931 P1476 "Evaluation of Efficacy and Safety of HMR1964 Intensive Therapy in Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled With Oral Hypoglycemic Agents (OHA); OHA Therapy Controlled, Open, Randomized, Parallel Group, Comparative (Superiority), 16-week, Multinational, Multicenter Study" @default.
- Q65538931 P17 Q17 @default.
- Q65538931 P2899 "+20" @default.
- Q65538931 P3098 "NCT00290927" @default.
- Q65538931 P31 Q30612 @default.
- Q65538931 P4135 "+75" @default.
- Q65538931 P4844 Q6042242 @default.
- Q65538931 P580 "2003-12-01T00:00:00Z" @default.
- Q65538931 P6099 Q42824827 @default.
- Q65538931 P6153 Q158205 @default.
- Q65538931 P8363 Q78089383 @default.